Dr Lal PathLabs' wholly-owned Dubai subsidiary incorporated a new step-down subsidiary, Dr Lal PathLabs Indomed LLC, in Tashkent, Uzbekistan.

Dr. Lal Path Labs Ltd.LALPATHLAB · Filed with the exchange

This expands its diagnostic services, with the subsidiary subscribing to 70% of the new entity's share capital at face value.

No comments yet. Be the first.

More from Dr. Lal Path Labs Ltd.

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.